MiraLAX is not as effective as GoLytely in bowel cleansing before screening colonoscopies

Michael Hjelkrem1, Joel Stengel, Mark Liu

  • 1Department of Medicine, Division of Gastroenterology, Brooke Army Medical Center, Fort Sam Houston, Texas 78234, USA. mhjelkrem@yahoo.com

Abstract

Insights

Polyethylene glycol (PEG) 3350 with Gatorade (MiraLAX) is less effective for colonoscopy bowel preparation than standard GoLytely. Patients found MiraLAX more satisfactory, but it did not improve polyp detection or reduce adverse events.

Area of Science:

  • Gastroenterology
  • Clinical Trials
  • Medical Devices & Equipment

Background:

  • Effective bowel preparation is crucial for successful colonoscopies, impacting costs, lesion detection, and procedure length.
  • Polyethylene glycol (PEG) 3350 without electrolytes (MiraLAX) combined with Gatorade is a popular, yet unproven, bowel preparation method.
  • Standard bowel preparations like GoLytely are well-established but can be less tolerable for patients.

Purpose of the Study:

  • To compare the efficacy and patient tolerability of MiraLAX-based bowel preparations against standard split-dose GoLytely.
  • To evaluate MiraLAX alone and in combination with bisacodyl or lubiprostone for colon cleansing.
  • To determine if MiraLAX offers a more satisfactory patient experience without compromising colon cleanliness.

Main Methods:

  • A prospective, randomized, blinded, controlled trial involving 403 patients.
  • Patients were assigned to receive either GoLytely, MiraLAX alone, MiraLAX with bisacodyl, or MiraLAX with lubiprostone.
  • Colon cleanliness was assessed using the Ottawa bowel preparation scale, and patient satisfaction/tolerability were surveyed.

Main Results:

  • GoLytely demonstrated superior bowel cleansing efficacy (lower Ottawa scores) compared to MiraLAX alone or with adjuncts (P<.001).
  • Patients reported higher overall satisfaction with MiraLAX-based preparations compared to GoLytely (P<.001).
  • No significant differences were observed in polyp detection rates or adverse events across the groups.

Conclusions:

  • Split-dose MiraLAX with Gatorade is less effective for bowel cleansing in screening colonoscopies than split-dose GoLytely.
  • While MiraLAX may improve patient satisfaction, its reduced efficacy impacts colon cleanliness.
  • Further research may explore optimizing MiraLAX regimens or identifying patient populations where its use is appropriate.

Related Concept Videos

Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Lower GI Series: Barium Enema01:23

Lower GI Series: Barium Enema

A Barium Enema, or a lower GI series, is a specialized radiographic examination designed to visualize the lower gastrointestinal tract, specifically the colon and rectum. This procedure is instrumental in diagnosing various conditions such as colorectal cancer, polyps, diverticulosis, and inflammatory bowel disease.
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...